-
Medtech Regulatory Dynamics 2020: 6 Big Regulatory Updates and Takeaways for Medtech Teams
2020 is expected to be a particularly eventful year for global medtech markets; be it due to brand new regulations, challenges to existing healthcare systems, updated trade agreements, unique...
-
CAR T-Cell Therapy: Engaging the Right Hospitals in Europe
CAR T-Cell Therapy: Engaging the Right Hospitals in Europe A Visual Guide to Locating Treatment Centers Growing from an estimated $172 million USD in 2020 to $1.35 billion USD by 2025 in major...
-
Type 2 Diabetes: Patient, Provider and Payer Trends and Planning Considerations
Find out which factors brands need to understand to get closer to their diabetes stakeholders and identify which activities have the greatest potential to impact outcomes. See below for patient,...
-
E-Books, Presentation, Webinars
Medtech Account Segmentation and Targeting Best Practices
Last year, there were over 900 healthcare merger and acquisition deals, transforming device purchasing dynamics and the level of influence across accounts and stakeholders. Today’s commercial teams...
-
What does Medtech need to know about the evolving role of the patient?
Hear what DRG Consultant, Paul O’Mahoney MD has to say about how patient interaction with healthcare is changing. Transcription: Yeah. So, what we're seeing now in the market is definitely an...
-
ePharma Physician® U.S 2019
ePharma Physician® U.S 2019 Sales rep disconnect underscores need for a multi-modal approach to physician engagement 1 REPS INCREASINGLY STRUGGLE FOR FACE TIME WITH BUSY PHYSICIANS; PHARMAS HAVEN’T...
-
Medtech Account Segmentation and Targeting
Last year, there were over 900 healthcare merger and acquisition deals, transforming device purchasing dynamics and the level of influence across accounts and stakeholders. Today’s medtech teams...
-
Pharma-owned channels are highly valued for patient offerings in EU5
Find out what are the top needs of EU5 physicians from pharma owned channels and how to deepen HCP engagement across pharma channels with the help of heatmap messaging analysis. Click on the...
-
Oncology Trends: Evolving Payer, Provider Landscape Aims for Greater Control Over Physicians
Consolidation and integration of payers/PBMs and of oncology providers means greater standardization of care, more providers at-risk for costs, and better coordination of care. The increasing cost-...
-
Greater Accuracy in Market Sizing
Greater Accuracy in Pharma Market Sizing Epidemiology + Real-World Evidence: The case for collaborative, agile research
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
